Maine
How labels make or break Maine’s recreational cannabis compliance system
A group of recreational cannabis flower products purchased in October at Brilliant Buds in Bethel were fully compliant with state requirements.
The stickers for the “Find.” brand products displayed required warnings, strain names, potency values, processor license information and batch identifiers.
But when the recreational stickers were peeled back after being purchased on Oct. 24, medical cannabis labels were found underneath. The labels included Curaleaf’s Auburn facility address and medical-style batch data. Curaleaf is one of the largest multistate medical cannabis operators in the United States.
Was it a labeling error? Was the product for medical use instead of recreational? Was it simply a case of recycled packaging?
Those questions and more are at the core of labeling irregularities in Maine’s cannabis packaging, verification and retail compliance model: repurposed or mislabeled consumer packages can move through intake, stocking and point-of-sale without triggering an alert.
One recreational-use bag labeled “Turnpike Cookies” revealed a medical label beneath it printed with the strain “MAC 1.” A second bag of “Mintz Snackz” had the same label. In both cases, the originally labeled strain name was faintly visible through the sticker.
The discovery does not establish wrongdoing or intentional misconduct, but it does raise questions for consumers and regulators who may not necessarily be able to distinguish if a product on the shelf had an old label that was not properly removed or if the product was intended for one market but was being sold in the other without following all required rules.
In the case of the layered labels at Brilliant Buds, it was all legal. Maine’s recreational cannabis rules do not prohibit layered labels, and the final, visible sticker is treated as the compliance record at retail.
With labels from different regulatory programs remaining visible beneath a retail sticker, however, it has created confusion among consumers who want to know exactly where their cannabis is from and raised questions about packaging quality control.
Under Maine rules, the label itself is the mechanism by which retail compliance is communicated and enforced. The Office of Cannabis Policy allows multiple labels on a recreational package, provided required information is not obstructed.
Maine’s recreational cannabis program includes mandatory testing, track and trace, stringent labeling and universal symbols. The medical cannabis program does not require mandatory testing or track & trace.
Kaspar Heinrici, chief executive director of SeaWeed Co. in Portland, said the recreational cannabis market operates under a level of scrutiny that is often misunderstood by the public.
“There is still a misperception that cannabis operators are putting a plant into a bag with little oversight,” he said. “The reality is that regulated recreational operators are working with a level of organization, testing and standard operating procedures closer to the medical or financial services industries.”
TRACING CANNABIS
Maine’s recreational system requires cannabis sold at retail to be identifiable for recall purposes through batch information printed on the label.
Heinrici said Maine’s batch-based approach is intended to balance public health protections with operational practicality.
“If there is an issue with one unit of a product, it likely extends to the rest of the package and potentially the package it came from,” he said. “Being overly specific at the individual unit level is not going to provide additional benefit.”
At the retail shelf, compliance and recall depend on the accuracy of the information printed on the visible retail label. Inspection quality can vary depending on staffing levels, lighting, workflow and training. Batch numbers are often printed in small type.
The rule does not require individual retail units, such as eighths, quarters, ounces or pre-rolls, to carry a unique electronic identifier, radio frequency identification tags or scannable code. But it does for cultivation and wholesale inventory movement.
Maine uses Metrc (short for Marijuana Enforcement Tracking Reporting Compliance) a track-and-trace inventory system adopted in many cannabis jurisdictions.
Other states use different track-and-trace platforms. For example, Connecticut uses BioTrack. In Connecticut, each retail cannabis unit carries a printed unit identification number with a machine-readable barcode, as well as a QR code with a link.
A Curaleaf “Ched-R-Cheez” cannabis label from Connecticut shows a printed unit identification number with a machine-readable barcode and a QR code intended to link consumers to batch-specific test results. (Courtesy photo)Curaleaf is headquartered in Stamford, Connecticut, and operates more than 150 operates medical and recreational dispensaries nationwide.
Maine consumers do not have a comparable consumer-facing verification tool.
Heinrici said that while testing and traceability are essential, additional regulatory layers do not always translate into better consumer outcomes.
“The track-and-trace and testing requirements are important for public health, but they verge on being overly detailed and overly burdensome for the end consumer,” he said. “More regulation always comes with a cost, and that cost ultimately shows up at the register.”
SHIFTING MARKET IN MAINE
Curaleaf entered Maine in 2016 through its relationship with Remedy Compassion Center, one of the state’s original eight nonprofit medical cannabis dispensaries and the first to open under Maine’s medical program.
While Curaleaf exited recreational retail storefronts in Maine in 2023, citing competitive pressures, the company remained active in the state’s medical cannabis program as well as recreational cultivation and manufacturing.
It appears Curaleaf is dipping its toes back into recreational retail. In late November, job postings for Curaleaf-managed operations at Brilliant Buds in Bethel signaled a return through a licensed partner rather than a Curaleaf-branded store. Additional Curaleaf job listings in Bangor indicate a recreational retail component planned for that location.
Curaleaf did not respond to repeated requests for comment for this article. Attempts to seek comment from Brilliant Buds were also unsuccessful.
A reporter visited the Bethel store in person but was asked to leave upon entry. A follow-up phone call to the store and subsequent emails seeking comment were not answered.
Office of Cannabis Policy Data Analytics Director Eric Miller said recently that recreational sales are strongest in western and southern Maine, particularly in border-adjacent regions near New Hampshire, a factor that may help explain Curaleaf’s focus on Bethel.
John Hudak, the director of Maine’s Office of Cannabis Policy, said sales data suggest some border effects, but emphasized they are not the primary driver of Maine’s recreational market.
“I think New Hampshire is having an impact in York and Cumberland County, but it’s not the major driver of Maine’s cannabis economy,” Hudak said, adding that tourism and Maine consumers account for most recreational sales.
MEDICAL vs. RECREATIONAL
Maine regulates cannabis under three distinct frameworks: medical cannabis, recreational cannabis and hemp-derived products. Each system operates under different statutes, labeling rules, testing standards and tax structures.
Recreational cannabis is overseen by the Office of Cannabis Policy and is subject to labeling rules, mandatory third-party testing, Metrc oversight and a 10% excise tax. As of late 2025, Maine lists roughly 180 licensed recreational cannabis stores, along with 78 cultivation facilities and 81 manufacturing facilities statewide.
According to data from the Maine Office of Cannabis Police, monthly taxable cannabis sales in Maine show medical sales peaking earlier and then leveling off, while recreational sales rise steadily after legalization, narrowing the gap between the two markets from 2022 through 2025. (Rebecca Richard/Staff Writer)Maine’s medical cannabis program is also overseen, separately, by the Office of Cannabis Policy. Maine lists 86 active medical dispensaries and approximately 1,554 registered caregivers statewide. A medical cannabis caregiver is an individual or business authorized to grow and sell cannabis directly to registered patients, often operating at smaller scale and under less prescriptive labeling and testing rules.
“From a caregiver standpoint, testing and transparency matter because trust is everything,” said a Franklin County-area medical cannabis caregiver who requested anonymity. “Even unintentional confusion around labeling or testing can make patients question whether a product is safe.”
In July, cPort Credit Union notified many medical cannabis caregivers and caregiver storefronts statewide that their business accounts would be closed, citing evolving compliance expectations and regulatory risk. The decision did not apply to licensed medical dispensaries, which are subject to higher levels of oversight.
“Patients ask more questions now than they did a few years ago,” said the Franklin County caregiver. “Public perception around safety is shaped as much by labeling and communication as by the product itself.”
The labeling incident in Bethel illustrates a possible hole in Maine’s recreational oversight model. Cultivation and wholesale movement can be tracked with some accuracy, but at the retail shelf things can get much more dicey, relying on individual inspectors and label accuracy — rather than actual traceability.
At the point of sale, the sticker is the system. Against that backdrop, state regulators are continuing broader discussions about testing standards and consumer protection.
The Office of Cannabis Policy hosted a Cannabis Conversation on Testing Lab Standards on Dec. 22, hosted by director Hudak, which focused on how the state and the Maine Center for Disease Control and Prevention work together to ensure certified cannabis testing labs, examining laboratory procedures, oversight and public health standards. The video can be watched on Maine OCP’s YouTube page.
Maine
Who is raising the most money in the Maine governor’s race?
(Joe Phelan/Staff Photographer)
Candidates vying to become Maine’s next governor have until midnight Tuesday to file campaign finance reports for the first quarter of the year.
The reports will show who is best positioned to control the message in the final month-plus until the primaries. But fundraising success doesn’t always guarantee a win at the ballot box.
The reports come as a growing number of leading candidates are taking to the airwaves a head of the June 9 primaries. Five Democrats and seven Republicans are vying to replace Gov. Janet Mills, who is term limited.
As of Tuesday, Republican Jonathan Bush topped all candidates in broadcast, cable and digital advertising, having booked nearly $1.5 million in ads through the primary, the political spending tracker AdImpact said.
But Republican Garrett Mason is benefitting from about $3 million in spending by Restoration of America PAC, which is running ads targeting Gov. Janet Mills and tying Mason to President Donald Trump.
Other Republican candidates running ads are Bobby Charles ($63,000), Owen McCarthy ($43,660) and Ben Midgely ($55,000.)
Hannah Pingree tops the Democratic slate with about $564,000 in ad spending, followed by Nirav Shah ($493,000), Shenna Bellows ($462,700) and Angus King III ($299,000.)
As of Tuesday afternoon, fundraising totals were only trickling in. Public access to those reports was hampered because the Maine Commission on Governmental Ethics & Election Practices is building a new website, and glitches made some reports unviewable.
This story will be updated when more reports are filed. As of Tuesday afternoon:
- Republican Jonathan Bush reported raising about $845,000 in the first quarter, but 60% of that, $500,000, was a personal loan to his own campaign. His totals were not yet available through the new website, but his quarterly fundraising and spending was provided by ethics staff.
- Republican Robert Wessels was the only other active candidate that had filed. He raised nearly $11,600 for the quarter and has about $13,540 in cash.
This is a developing story.
Maine
Obituary: Anne Theresa Tarling
Anne Theresa Tarling
SANFORD – Anne Theresa Tarling, 74, of Sanford, Maine passed away peacefully at home on April 23, 2026, surrounded by her loving family. While our hearts are broken, we find comfort in knowing she lived a full and beautiful life rooted in love, creativity, and devotion to the people who meant the most to her.
Anne was born on April 3, 1952, in Portland, Maine, to the late Joseph and Blanche Morin. She grew up in Portland and graduated from Deering High School in 1970.
In 1980, Anne married the love of her life, Ernest Tarling. Together they built a life centered on family, laughter, and partnership. Their 45 years of marriage were filled with shared memories and a deep commitment to one another and to their family.
Anne was a talented self-taught artist who found great joy in painting and sharing her creativity with others. She proudly exhibited her work at local art shows and specialty shops, and her paintings found their way into homes near and far. Her art brought beauty and comfort to many and will continue to remind us of her for years to come.
She also enjoyed gardening, sailing the coast of Maine, and hosting family gatherings. She was known for her famous chocolate chip cookies and for never missing a birthday or special occasion.
Being a devoted Nana brought her great joy, and she cherished time spent with her family above all else.
In addition to her parents, Anne was preceded in death by her brother, Stephen Morin; her sister, Julie Pochebit, her brother-in-law, Daniel Desmond; nieces Elizabeth McKee and Alison Pochebit.
She is survived by her brother, Paul (Sue Ellen) Morin, two sisters, Cheryl Desmond and Celine (Stephen) Pochebit; her husband of 45 years, Ernest Tarling; her son, Greg (Karen) Flagg, her four daughters, Jennifer Copper, Rebecca (Frank) Zavadil, Stefenie (Matthew) Burdick, and Kendra (Justin) Dowling; her 11 grandchildren, Cody, Matthew, Jackson, Gracey, Lucas, Quinn, Beau, Shea, Ellie, Will, and Stevie; a large extended family, including many loving nieces and nephews; and her longtime best friend, Sandy Hobbs.
A funeral service will be held Saturday, May 2, at 11 a.m. at St. Martha Church, 30 Portland Road, Kennebunk, Maine, followed by a celebration of life at 12:30 p.m. at For the Love of Food + Drink at Saltwater Farm, 411 Post Road, Wells, Maine.
To share a memory or leave a message of condolence, please visit Anne’s Book of Memories Page at http://www.bibberfuneral.com.
Arrangements are in the care of Bibber Memorial Chapel, 67 Summer Street, Kennebunk, ME 04043.
Maine
Moldy Maine weed is being treating with radiation
Maine marijuana growers are increasingly using radiation and other methods to remove contaminants from their products, a process consumers are likely in the dark about.
Despite a state policy requiring remediated products to be labeled as such, Maine’s Office of Cannabis Policy is not enforcing that rule.
In response to a complaint by a dispensary owner in late February, deputy director of operations Vern Malloch acknowledged, “we are not requiring labeling of remediated or treated product,” according to records obtained through a media request.
“We plan to issue guidance on this in the near future,” Malloch wrote.
Office of Cannabis Policy Director John Hudak also told lawmakers last year that the agency hasn’t enforced remediation labeling requirements since at least November 2024.
“The Office began receiving pushback from cannabis cultivators who did not want to label their cannabis if they ‘treated’ their cannabis with radiation or ozone prior to submitting the cannabis for mandatory testing,” Hudak wrote in testimony last year.
A spokesperson for the agency declined to answer specific questions Monday, but confirmed the agency stopped enforcing the rule after some growers raised concerns over the “misleading impact” that labeling treated cannabis has on consumers.
“Requiring label disclosure of the use of irradiation or ozone treatment implies a consumer risk that is not scientifically supported and is potentially misleading in its implication about potential harm from exposure,” Alexis Soucy, OCP’s director of media relations, wrote in an email.
Over the last couple years, several marijuana products have been subjected to recall because of high levels of mold, yeast and other contaminants. Unsafe levels of mold in cannabis can cause flu-like symptoms, including respiratory issues, sinus infections, headaches and dizziness.
But rather than tossing their product, growers can turn to a process called irradiation, often involving gamma rays or X-rays, to remove contaminants.
Supporters say it’s a safe way to reduce waste and prolong shelf lives. Mold and yeast grow naturally just about everywhere and many species are benign. Standard cannabis mold testing does not differentiate between harmful and harmless microbes.
Opponents, however, argue there isn’t enough research about remediating cannabis to say whether it’s safe or not. There is not much data on whether the various types of remediation are effective at killing microbes or are safe for consumers, most of whom don’t know about the practice.
“It’s a complex topic without many answers,” said Yasha Kahn, who co-founded MCR Labs, one of four licensed cannabis testing facilities in Maine. “Hopefully, the rescheduling can lead to more research.”
The federal government moved last week to reclassify cannabis from a Schedule I to Schedule III drug. Decades-long restrictions on cannabis research will be lifted, which acting Attorney General Todd Blanche said will allow for studies into “marijuana’s safety and efficacy.”
Kahn, who operates several testing labs throughout New England, said irradiating cannabis has become increasingly prevalent in legal markets across the country and the world. It’s still debated whether irradiation works as well as it’s supposed to, he said.
‘THIS IS A FAIRLY NEW PROCESS’
There are numerous kinds of cannabis remediation, each with its own pros and cons. Growers most commonly use X-rays, gamma radiation or ozone gas to remove mold and microbes.
Radiation does not kill all the mold, yeast and other microbes present in cannabis outright, Kahn said. Certain species of mold, like harmful mycotoxins, can often survive remediation. Others can remain dormant for months following the procedure.
“Irradiation gets rid of mold’s ability to procreate, and not necessarily permanently,” he said. “You can take that same product and test it again, months from then, and there’s going to be mold growth.”
Some in the industry, like organic marijuana farmer Lizzy Hayes in Mercer, fear that having the option to remediate cannabis removes the incentive to grow clean cannabis. If you can simply use radiation to eliminate mold from harvested crops, she said, why would you put effort into growing mold-free products?
Part of the blame, according to Hayes, lies at the feet of Maine’s recreational cannabis testing regime. Unlike the state’s medical marijuana market, batches of recreational cannabis products must be tested for contaminants like mold, yeast and heavy metals before they can be put on a dispensary shelf.
But since the mold test only detects the presence of mold, not whether it’s harmful, Hayes said many growers save themselves the trouble and irradiate their cannabis by default rather than risking a failed test.
“When you have a regulatory system that incentivizes irradiation, it’s also making it so that customers don’t have access to as high quality of a product,” she said.
Some in the industry disagree. A bill was proposed last year to codify requirements around labeling treated cannabis and inspecting remediation equipment. It was ultimately defeated after many Maine cannabis growers testified in opposition to the bill.
“Radiation and ozone treatment methods are well-established, scientifically validated technologies commonly used in industries far beyond cannabis,” wrote Jacob Racioppi, owner of Goose River Cannabis in Unity. “In fact, they are standard in the food industry.”
Joel Pepin, co-founder of JAR Cannabis Company, owns and operates one of about a dozen X-ray machines in Maine’s cannabis industry. He estimated that about half of Maine’s recreational cannabis has been treated by similar methods. It would be overkill, he said, to require all of that product to be labeled over scientifically unfounded concerns.
“If we apply this same logic to other industries in Maine, then why doesn’t this bill also require dental patients to wear a shirt that says, ‘treated by X-ray’ after leaving the dental office?” Pepin testified.
Neither Racioppi nor Pepin responded to requests for an interview.
Lorri Maling, laboratory director at cannabis testing facility Nelson Analytical, seconded Pepin that remediating cannabis is “more in use now than it was a few years ago.”
While some opponents of irradiation claim the process reduces THC content and eliminates terpenes — the chemicals that give different cannabis strains unique scents and effects — Maling said there’s no data to back that up. Nor is there much data to back up many other conclusions about the effects of irradiating cannabis.
Most of the studies on the effects of irradiation have been on fruits and vegetables, she said, which have not shown any negative effects — though there’s no guarantee that any remediation method will kill all bacteria.
“This is a fairly new process for cannabis,” Maling wrote in an email. “I really cannot say that it is safe or unsafe for cannabis as there really is not enough data on this.”
-
New York12 minutes agoFather and Daughter Who Sold Fake Warhols Plead Guilty in Forgery Scheme
-
Detroit, MI42 minutes agoJackson Jobe throws first bullpen in return from Tommy John surgery
-
San Francisco, CA54 minutes ago
Oakland, California, airport can use ‘San Francisco’ in name after settlement
-
Dallas, TX1 hour ago
Cowboys LB coach ‘feels really good’ after NFL draft, new additions
-
Miami, FL1 hour ago2 more Miami Beach Commissioners endorse Vicki Lopez for Miami-Dade Commission
-
Boston, MA1 hour ago99 Restaurant in Charlestown may close for apartments
-
Denver, CO1 hour agoRe/Max to be sold, headquarters to leave Denver
-
Seattle, WA1 hour agoSeattle’s drug diversion plan falters as open-air use persists in neighborhood hotspots